Sibannac, Inc. Announces Development of Functional Mushroom Products and Moringa to Expand Wellness Portfolio
Sibannac, Inc. (SNNC) Announces Joint Venture With 1120 Management, LLC to Develop State-of-the-Art DEA-Compliant Psilocybin Research Facility in Phoenix, Arizona
Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch
Sibannac, Inc. (OTC:SNNC) Announces Strategic Marketing & Revenue Acceleration Partnership With Small Cap Access
Sibannac, Inc. Begins Taking Reservations For Its Ayahuasca Retreat At World-Renowned Rythmia In Costa Rica
Sibannac, Inc. Announces Its Inaugural Plant Medicine Retreat At Rythmia In Costa Rica
Sibannac, Inc. and 4biddenknowledge Forge Strategic Partnership to Accelerate Global Psychedelic Retreats
Sibannac, Inc. and 4biddenknowledge, Inc. Record First Podcast in Planned Series
Sibannac, Inc. and 4biddenknowledge, Inc. Announce Co-Marketing Partnership to Launch Podcasts, Plant-Medicine Retreats, and Innovative Wellness Products
Sibannac, Inc. Announces Luxury Plant-Based Wellness Tourism with U.S. and International Retreats
Sibannac Expands into Booming $1.4 Trillion Wellness Tourism Market with Starwalker Journeys
Sibannac Launches Starwalker Cafe - A Transformational Hub for Consciousness Exploration, Wellness Journeys, and Lifestyle Growth
Sibannac, Inc. and Higher Times Announce Strategic Joint Venture to Expand Consciousness and Wellness Project Offerings
SIBANNAC, INC. RETURNS 102,233,482 RESERVED SHARES BACK TO THE TREASURY
SIBANNAC, INC. LAUNCHES THE CAMPUS CO.
SIBANNAC, INC. PROVIDES UPDATE TO SHAREHOLDERS
SIBANNAC, INC. ANNOUNCES ENTRY INTO MEMORANDUM OF UNDERSTANDING TO ACQUIRE STELLAR CHEMICAL CORP.